Said Jaap Goudsmit.

In 2004, began to develop Aeras and Crucell share this vaccine candidate with Crucell ADVA vaccine technology and PER. 2007 24.000 I am extremely concerned about the momentum of developing our work in the next-generation vaccine against TB preceded pleased Our successful collaboration with Aeras, and that the initiation of another Phase II study is an important step towards our goal of reducing this deadly disease this deadly disease, said Jaap Goudsmit, Crucell Chief Scientific Officer. – Kenya number 13 on the list of the 22 most polluted TB countries, according to the World Health Organization.

Source: Annmarie Leadman Aeras Global TB Vaccine FoundationDutch biopharmaceutical company Crucell NV and the Aeras Global TB Vaccine Foundation has at the start of a Phase II trial announced infants of the jointly developed tuberculosis vaccine AERAS-402/Crucell Ad35.– Stock humans who require special assistance as elderly people living alone, persons with disabilities and child need test.

Related Articles

Other Articles from "pharmacy":